Apalutamide is a nonsteroidal androgen receptor antagonist used as a pharmaceutical raw material for the manufacturing of medications indicated in castration-resistant prostate cancer. It selectively binds to the androgen receptor ligand-binding domain, blocking nuclear translocation and transcription of androgen receptor gene targets.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 956104-40-8
Apalutamide Dithio Impurity
Active pharmaceutical ingredient impurity
Apalutamide Di-(2-fluoro-N-methylbenzamide)
active pharmaceutical ingredient impurity
Apalutamide metabolite M2
active pharmaceutical ingredient metabolite
Methyl 4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluorobenzoate
research compound
Ranolazin
active pharmaceutical ingredient
Ranolazine dihydrochloride
active pharmaceutical ingredient
Fluindione
vitamin K antagonist anticoagulant
Delta9,11-Eplerenone
active pharmaceutical ingredient
4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide
HJBWBFZLDZWPHF-UHFFFAOYSA-N
CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F